Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard Naspro

Showing results (71-80 of 79) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 79 results.
World Journal of Urology|December 26, 2024
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre seriesMarco Finati, Antonio Fanelli, Francesco Cinelli, et al.
Clinical Genitourinary Cancer|June 5, 2020
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?Marco Roscigno, Armando Stabile, Giovanni Lughezzani, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 16, 2017
Perioperative antithrombotic therapy in patients undergoing endoscopic urologic surgery: where do we stand with current literature?Richard Naspro, Lori B Lerner, Roberta Rossini, et al.
European Urology Open Science|November 24, 2025
Refining Active Surveillance Eligibility in Intermediate-risk Non-muscle-invasive Bladder Cancer: The Impact of Time to First RecurrenceMarco Finati, Nicola Schiavone, Biagio Barone, et al.
European Urology|March 27, 2017
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysisKari A O Tikkinen, Samantha Craigie, Arnav Agarwal, et al.
Healthcare (Basel, Switzerland)|March 28, 2024
Effectiveness of Preoperative Immunonutrition in Improving Surgical Outcomes after Radical Cystectomy for Bladder Cancer: Study Protocol for a Multicentre, Open-Label, Randomised Trial (INu-RC)Valentina Da Prat, Lucia Aretano, Marco Moschini, et al.
European Urology|March 13, 2017
Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysisKari A O Tikkinen, Samantha Craigie, Arnav Agarwal, et al.
Cancers|October 14, 2023
Oncological Outcomes of Patients with High-Volume mCRPC: Results from a Longitudinal Real-Life Multicenter CohortMariaconsiglia Ferriero, Francesco Prata, Umberto Anceschi, et al.
BJU International|February 22, 2012
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvisMarco Roscigno, Eugene K Cha, Michael Rink, et al.
Pageof 8

Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
World Journal of Urology|December 26, 2024
Oncological outcomes and prognostic implications of T1 histo-anatomic substaging in the management of high-Grade non-muscle invasive bladder cancer: results from a large single centre seriesMarco Finati, Antonio Fanelli, Francesco Cinelli, et al.
Clinical Genitourinary Cancer|June 5, 2020
The Use of Multiparametric Magnetic Resonance Imaging for Follow-up of Patients Included in Active Surveillance Protocol. Can PSA Density Discriminate Patients at Different Risk of Reclassification?Marco Roscigno, Armando Stabile, Giovanni Lughezzani, et al.
Minerva Urologica E Nefrologica = the Italian Journal of Urology and Nephrology|December 16, 2017
Perioperative antithrombotic therapy in patients undergoing endoscopic urologic surgery: where do we stand with current literature?Richard Naspro, Lori B Lerner, Roberta Rossini, et al.
European Urology Open Science|November 24, 2025
Refining Active Surveillance Eligibility in Intermediate-risk Non-muscle-invasive Bladder Cancer: The Impact of Time to First RecurrenceMarco Finati, Nicola Schiavone, Biagio Barone, et al.
European Urology|March 27, 2017
Procedure-specific Risks of Thrombosis and Bleeding in Urological Cancer Surgery: Systematic Review and Meta-analysisKari A O Tikkinen, Samantha Craigie, Arnav Agarwal, et al.
Healthcare (Basel, Switzerland)|March 28, 2024
Effectiveness of Preoperative Immunonutrition in Improving Surgical Outcomes after Radical Cystectomy for Bladder Cancer: Study Protocol for a Multicentre, Open-Label, Randomised Trial (INu-RC)Valentina Da Prat, Lucia Aretano, Marco Moschini, et al.
European Urology|March 13, 2017
Procedure-specific Risks of Thrombosis and Bleeding in Urological Non-cancer Surgery: Systematic Review and Meta-analysisKari A O Tikkinen, Samantha Craigie, Arnav Agarwal, et al.
Cancers|October 14, 2023
Oncological Outcomes of Patients with High-Volume mCRPC: Results from a Longitudinal Real-Life Multicenter CohortMariaconsiglia Ferriero, Francesco Prata, Umberto Anceschi, et al.
BJU International|February 22, 2012
International validation of the prognostic value of subclassification for AJCC stage pT3 upper tract urothelial carcinoma of the renal pelvisMarco Roscigno, Eugene K Cha, Michael Rink, et al.
Pageof 8